Key result
Triple NOS deletion in mice drives ~21% heart proteome remodeling with enhanced Mapk signaling.
Why the study?
Diminished nitric oxide bioavailability contributes to cardiometabolic disorders, but the resulting signaling alterations remain mostly unknown.
Severe NO signaling deficit in tNOS null mice leads to significant proteomic remodeling and maladaptive Mapk3/Mapk1 signaling, which may promote pathological cardiomyopathy.
Highlights NOS redundancy in preserving cardiac proteome in mice; leaves open relevance to human heart failure with NO signaling deficits.
Diminished bioavailability of nitric oxide (NO) contributes to the pathogenesis of cardiometabolic disorders. However, the alterations in signaling under NO deficiency remain mostly unknown. We combined genetics and proteomics to quantify changes in the heart proteome, phosphoproteome, and S-nitrosocysteine proteome in mice lacking nitric oxide synthases (NOS1, NOS2, NOS3), lacking all three enzymes (tNOS), or the alpha 1-regulatory subunit of the soluble guanylate cyclase (sGCα1). Modest changes of less than 1% in the proteome and 4% in the phosphoproteome in single NOS gene or sGCα1 null mouse hearts indicate sufficient biological compensation. In contrast, the number of S-nitrosylated proteins declined by 80%, 57%, and 35% in NOS3, NOS1, and NOS2 null mice, respectively. A 21% remodeling of the proteome and 9% of the phosphoproteome in the tNOS null mice included integral kinases that provide adaptive rewiring of signaling. The data revealed the emergence of enhanced mitogen-activated-kinases Mapk3/Mapk1 signaling, documented by increased phosphorylation of these kinases and their downstream targets. The data highlight that adaptive compensation of signaling prevents overt phenotypes during NO signaling deficits. In contrast, maladaptive signaling via Mapk3/Mapk1 may promote pathological cardiomyopathy that progressively develops in the tNOS null mice.
No takes yet. Share an insight, caveat, or question.
Mohanty et al. (2025) studied Nitric oxide/cGMP signaling deficiency (n=28). Genetic deletion of nitric oxide synthases (NOS1, NOS2, NOS3, tNOS) or sGCα1 vs. Wild-type C57BL/6J mice was evaluated on Changes in the heart proteome, phosphoproteome, and S-nitrosocysteine proteome. Mice lacking all three nitric oxide synthases exhibited a 21% remodeling of the heart proteome and 9% of the phosphoproteome with enhanced Mapk3/Mapk1 signaling, whereas single NOS deletions showed minimal proteomic changes but up to an 80% decline in S-nitrosylated proteins.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: